Current possibilities of ultrasonography in diagnosing local spread of endometrial cancer

Cover Page

Cite item

Abstract

Background. The incidence of oncologic pathology in the female reproductive system is continually rising, highlighting the importance of finding new methods for early and precise diagnosis. This study aimed to determine the invasion depth of endometrial cancer through contrast-enhanced ultrasonography.

Materials and methods. The study included 38 patients who were confirmed to have endometrial cancer. All patients underwent complex ultrasound examinations in real-time and grayscale mode. The qualitative assessment of vascularization in color and energy Doppler mapping modes was performed using contrast enhancement with the assessment of qualitative and quantitative parameters of contrast.

Results. The results were compared with histological examination results from postoperative materials. The study identified contrasting qualitative parameters that are most indicative of endometrial cancer and quantitative parameters that are statistically significant and reliably distinguished the myometrium affected by the tumor from the unaffected myometrium (including peak intensity, time to peak intensity, and contrast half-life).

Conclusions. Contrast enhancement increases the effectiveness of comprehensive ultrasonography in determining the invasion depth of endometrial cancer.

About the authors

Kheda B. Zuzieva

P.A. Herzen Moscow Cancer Research Institute ― branch of the «National Medical Center of Radiology»

Author for correspondence.
Email: kheda.zuzieva@yandex.ru
ORCID iD: 0000-0002-1846-049X

Graduate Student, Junior Research Associate

Russian Federation, Moscow

Larisa A. Mitina

P.A. Herzen Moscow Cancer Research Institute ― branch of the «National Medical Center of Radiology»

Email: lmitina@list.ru
ORCID iD: 0000-0002-3563-7293

MD, Dr. Sci. (Med.)

Russian Federation, Moscow

Aleksandr N. Vostrov

P.A. Herzen Moscow Cancer Research Institute ― branch of the «National Medical Center of Radiology»

Email: Alexandr-V65@yandex.ru
ORCID iD: 0000-0001-7653-8008

MD, Dr. Sci. (Med.)

Russian Federation, Moscow

Svetlana V. Mukhtarulina

P.A. Herzen Moscow Cancer Research Institute ― branch of the «National Medical Center of Radiology»

Email: svmukhtarulina@yandex.ru
ORCID iD: 0000-0001-7481-9631

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Stanislav O. Stepanov

P.A. Herzen Moscow Cancer Research Institute ― branch of the «National Medical Center of Radiology»

Email: stanislav.o.stepanov@gmail.ru
ORCID iD: 0000-0001-8804-2237

MD, Dr. Sci. (Med.)

Russian Federation, Moscow

References

  1. Kaprin AD, Starinskii VV, Shakhzadova AO, editors. The state of oncological care to the population of Russia in 2022. Moscow: P.A. Herzen Moscow State Medical Research Institute ― branch of the Federal State Budgetary Institution “National Medical Center of Radiology” of the Ministry of Health of Russia; 2022. (In Russ).
  2. Association of Oncologists of Russia, Russian Society of Clinical Oncology, Russian Society of Specialists in the Prevention and Treatment of tumors of the Reproductive System. Clinical recommendations “Cancer of the uterine body and uterine sarcoma ― 2021-2022-2023 (20.01.2023)”. Approved by the Ministry of Health of the Russian Federation. Moscow: Ministry of Health of the Russian Federation; 2021. (In Russ).
  3. Weskott H.-P. Contrast-enhanced ultrasound. 1st ed. Bremen: UNI-MED; 2014. (In Russ).
  4. Dietrich CF, Averkiou M, Nielsen MB, et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound Int Open. 2018;4(1):E2–E15. doi: 10.1055/s-0043-123931
  5. Vostrov AN. Kompleksnaya ul’trazvukovaya diagnostika raka endometriya: [dissertation]. Moscow; 2002. Available from: https://search.rsl.ru/ru/record/01002304471?ysclid=lnrtjtuniv653479665 (In Russ).
  6. Nazarova IS. Ultrasound scanning in the diagnosis of malignant tumors of the uterus and ovaries. In: Ultrasound diagnostics in Oncology. Collection of materials of the First All-Union school. Moscow: Vysshaya shkola; 1988. P: 108–111. (In Russ).
  7. Myagkova AA. Ul’trazvukovye kriterii mikroinvazivnogo raka endometriya [dissertation]. Moscow; 2006. Available from: https://medical-diss.com/medicina/ultrazvukovye-kriterii-mikroinvazivnogo-raka-endometriya (In Russ).
  8. Chekalova MA, Barinov VV, Sinyukova GT, Kozachenko VP, Bokina LI. Ultrasonography in diagnosis of endometrial cancer. Vestnik Rossiiskogo onkologicheskogo nauchnogo tsentra im. N.N. Blokhina. 1999;10(4):44–50. (In Russ).
  9. Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018;39(2):e2–e44. doi: 10.1055/a-0586-1107
  10. Ashrafyan LA, Kharchenko NV, Ogryzkova VL, et al. Modern possibilities of sonography in the primary and clarifying diagnosis of endometrial cancer. Voprosy onkologii. 1999;45:87–92. (In Russ).
  11. Epstein E, Fischerova D, Valentin L, et al. Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study. Ultrasound Obstet Gynecol. 2018;51(6):818–828. doi: 10.1002/uog.18909
  12. Green RW, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging. Ultrasound Obstet Gynecol. 2020;56(1):96–105. doi: 10.1002/uog.21885
  13. Testa AC, Ferrandina G, Fruscella E, et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study. J Ultrasound Med. 2005;24(9):1267–1278. doi: 10.7863/jum.2005.24.9.1267
  14. Liu Y, Tian J-W, Xu Y, Cheng W. Role of transvaginal contrast-enhanced ultrasound in the early diagnosis of endometrial carcinoma. Chin Med J (Engl). 2012;125(3):416–421.
  15. Song Y, Yang J, Liu Z, Shen K. Preoperative evaluation of endometrial carcinoma by contrast-enhanced ultrasonography. BJOG. 2009;116(2):294–298. doi: 10.1111/j.1471-0528.2008.01981.x
  16. Liu Y, Xu Y, Cheng W, Liu X. Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms. Oncol Lett. 2016;12(5):3763–3770. doi: 10.3892/ol.2016.5206
  17. Lieng M, Qvigstad E, Dahl GF, Istre O. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol. 2008;32(7):935–940. doi: 10.1002/uog.6267
  18. Zhou H-L, Xiang H, Duan L, et al. Application of Combined Two-Dimensional and Three-Dimensional Transvaginal Contrast Enhanced Ultrasound in the Diagnosis of Endometrial Carcinoma. Biomed Res Int. 2015;2015:292743. doi: 10.1155/2015/292743
  19. Min’ko BA, Gelbutovskaya SM, Karlova NA, Boitsova MG, Zorin YaP. Experience in using modern ultrasound techniques for the diagnosis of endometrial cancer. Vrach-aspirant. 2018;(5):38–51. (In Russ).
  20. Zuzieva KhB, Mitina LA, Vostrov AN, et al. The use of sonohysterosalpingography in the diagnosis of endometrial pathology. P.A. Herzen Journal of Oncology. 2020;9(6):3438. (In Russ). doi: 10.17116/onkolog2020906134
  21. Zuzievа KhB, Mitina LA, Vostrov AN, et al. The use of echocontrast agents in ultrasound diagnosis оf endometrial cancer (literature review). V.F. Snegirev Archives of Obstetrics and Gynecology, Russian journal. 2020;7(2):80–83. (In Russ). doi: 10.18821/2313-8726-2020-7-2-80-83

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Arterial phase of contrast in endometrial cancer (homogeneous iso contrast without clear contours): a ― in contrast mode; b ― in the gray scale mode.

Download (326KB)
3. Fig. 2. Venous phase of contrast in endometrial cancer (hypocontrasting due to earlier leaching of contrast from the tumor compared to intact myometrium): a ― in contrast mode, the arrow shows the contour of the tumor; b ― in the gray scale mode.

Download (139KB)

Copyright (c) 2023 Eco-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).